A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

507

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic SyndromeSystemic Mastocytosis
Interventions
DRUG

Nilotinib

Trial Locations (101)

1000

Novartis Investigative Site, Brussels

1211

Novartis Investigative Site, Geneva

2065

Novartis Investigative Site, St Leonards

3000

Novartis Investigative Site, Leuven

3181

Novartis Investigative Site, Prahran

4031

Novartis Investigative Site, Basel

5000

Novartis Investigative Site, Adelaide

5530

Novartis Investigative Site, Yvoir

7100

Novartis Investigative Site, Haine-Saint-Paul

10017

Memorial Sloan Kettering Cancer Center, New York

10043

Novartis Investigative Site, Orbassano

13273

Novartis Investigative Site, Marseille

13353

Novartis Investigative Site, Berlin

14263

Roswell Park Cancer Institute Rosewell SC, Buffalo

14642

University of Rochester Medical Center, Rochester

16132

Novartis Investigative Site, Genova

20162

Novartis Investigative Site, Milan

20246

Novartis Investigative Site, Hamburg

20900

Novartis Investigative Site, Monza

21034

Novartis Investigative Site, Dijon

21231

Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Div.of Hematologic Malignancie, Baltimore

24128

Novartis Investigative Site, Bergamo

27100

Novartis Investigative Site, Pavia

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27710

Duke University Medical Center, Durham

33076

Novartis Investigative Site, Bordeaux

33612

H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt, Tampa

35019

Novartis Investigative Site, Rennes

37212

Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services, Nashville

38138

The Jones Clinic, Germantown

40138

Novartis Investigative Site, Bologna

40225

Novartis Investigative Site, Düsseldorf

46107

Indiana Blood and Marrow Institute Dept of Indiana Blood&Mar (2), Beech Grove

48109

University of Michigan Health System Clinical Trials Office, Ann Arbor

48201

Wayne State University, Detroit

54511

Novartis Investigative Site, Vandœuvre-lès-Nancy

55131

Novartis Investigative Site, Mainz

55905

Mayo Clinic - Rochester, Rochester

59037

Novartis Investigative Site, Lille

60590

Novartis Investigative Site, Frankfurt/M

60637

University of Chicago Medical Center Dept. of U. of Chicago Hosp(3), Chicago

65124

Novartis Investigative Site, Pescara

68169

Novartis Investigative Site, Mannheim

69437

Novartis Investigative Site, Lyon

70121

Ochsner Clinic Foundation, New Orleans

77030

MD Anderson Cancer Center/University of Texas, Houston

80045

University of Colorado Hospital, Aurora

80131

Novartis Investigative Site, Napoli

81675

Novartis Investigative Site, München

83301

Novartis Investigative Site, Niaosong Township

86021

Novartis Investigative Site, Poitiers

87042

Novartis Investigative Site, Limoges

89124

Novartis Investigative Site, Reggio Calabria

91010

City of Hope National Medical Center, Duarte

94010

Novartis Investigative Site, Créteil

97239

Oregon Health Sciences University, Portland

98104

Swedish Cancer Institute, Seattle

169608

Novartis Investigative Site, Singapore

94305-5750

Stanford University Medical Center, Stanford

Unknown

University of Illinois at Chicago Divisionof Hematology/Oncology, Chicago

Novartis Investigative Site, Pokfulam

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Grafton

02115

Dana Farber Cancer Institute, Boston

07601

Hackensack University Medical Center, Hackensack

A-1090

Novartis Investigative Site, Vienna

V5Z 4E3

Novartis Investigative Site, Vancouver

M5G 2M9

Novartis Investigative Site, Toronto

H1T 2M4

Novartis Investigative Site, Montreal

H3A 1A1

Novartis Investigative Site, Montreal

DK-7100

Novartis Investigative Site, Vejle

FIN-00029

Novartis Investigative Site, HUS Helsinki

04103

Novartis Investigative Site, Leipzig

00144

Novartis Investigative Site, Roma

00161

Novartis Investigative Site, Roma

00168

Novartis Investigative Site, Roma

1081 HV

Novartis Investigative Site, Amsterdam

NO-0310

Novartis Investigative Site, Oslo

40-635

Novartis Investigative Site, Katowice

90-153

Novartis Investigative Site, Lodz

02-097

Novartis Investigative Site, Warsaw

02-776

Novartis Investigative Site, Warsaw

50-367

Novartis Investigative Site, Wroclaw

519-809

Novartis Investigative Site, Hwasun-gun

05505

Novartis Investigative Site, Seoul

137-701

Novartis Investigative Site, Seoul

700 - 721

Novartis Investigative Site, Taegu

08036

Novartis Investigative Site, Barcelona

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

SE-413 45

Novartis Investigative Site, Gothenburg

SE-581 85

Novartis Investigative Site, Linköping

SE-221 85

Novartis Investigative Site, Lund

SE-751 85

Novartis Investigative Site, Uppsala

B15 2TH

Novartis Investigative Site, Birmingham

CB2 2QQ

Novartis Investigative Site, Cambridge

G12 OYN

Novartis Investigative Site, Glasgow - Scotland

LS9 7TF

Novartis Investigative Site, Leeds

L7 8XP

Novartis Investigative Site, Liverpool

SE5 9RS

Novartis Investigative Site, London

W12 0NN

Novartis Investigative Site, London

NE1 4LP

Novartis Investigative Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY